Abt 263 msds sheets

Msds sheets

Abt 263 msds sheets


Trifluoromethyl) sulfonyl] phenyl] sulfonyl] sheets benzamide abt ABT 263 ABT- 263 CAS number. ABT- 263 ( Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT- 737. com - com GHS Label elements including precautionary statements Pictogram Signal word Hazard and precautionary statements Section 2. Hazards Identification Section 1. The IUPAC name of this chemical is 4- [ 4- [ [ chloropheny. Research and development. Manufacture of substances. Navitoclax is msds an orally sheets bioavailable, also known as ABT- 263 synthetic small- molecule antagonist of a subset of the B- cell leukemia 2 ( Bcl- 2) family of proteins with potential antineoplastic activity.


Abt 263 msds sheets. Product Name: ABT- 263 ( Navitoclax) sheets Revision Date: 8/ 30/ Safety Data Sheet( SDS) I. Relevant identified uses of the substance abt mixture uses advised against sheets Identified uses Laboratory reagent. PRODUCT msds abt COMPANY IDENTIFICATION Product Name: ABT- 263 ( Navitoclax) Product Catalog abt Number: msds A3007 CAS Number: Company: APExBIO Technology 7505 Fannin street, Houston, Suite 410, TX 77054 USATELFAX. ABT- abt 263 disrupts Bcl- 2 - Bcl- XL interactions with pro- apoptotic proteins.

Details of the supplier of the safety data sheet Supplier Carbosynth Ltd. Product Name msds ABT- 263 Chemical Name ( Synonyms) Navitoclax ALKT Laboratories Inc 545 Phalen Blvd. The ABT msds 263 is an organic compound with the formula sheets C 47 H 55 ClF 3 N 5 O 6 S 3. Paul, MN 55130 USA Ph: Fax: www.


Msds sheets

Buy ABT 263 ( CAS, an inhibitor of antiapoptotic Bcl- 2 proteins, from Santa Cruz. ABT 263 is a novel inhibitor of antiapoptotic BCL- 2 proteins and a. Hazard Description: Toxic. Contains a pharmaceutically active ingredient. Handling should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients.

abt 263 msds sheets

ABT- 263 ( NavitoclaxReference standards for Pharmacological research. ABT- 263 is an orally sellecitive inhibitor of B- cell leukemia 2 ( Bcl- 2) family of proteins with potential antineoplastic activity.